Related by context. Frequent words. (Click for all words.) 70 pharmacokinetic 67 Phase 2b study 67 Phase IIa trial 66 multiple ascending dose 66 Phase 2a trial 66 phase 2a 65 pharmacokinetics 65 Phase IIa 65 Phase Ib 65 single ascending dose 64 phase IIa 64 phase IIb 64 Phase 2a clinical 63 placebo controlled trials 63 vitro studies 63 Phase 2a 63 Phase 1b clinical 63 pharmacodynamics 62 Phase 2b trial 62 pharmacodynamic 62 Menerba 62 preclinical studies 62 Phase IIb trial 62 Phase 1b 62 dose escalation trial 62 Pharmacokinetic 62 tolerability profile 61 Phase IIa clinical 61 Phase III trials 61 bioequivalence 61 Phase IIb clinical 61 pharmacokinetic profile 61 clinical trials 61 Phase IIb 60 SILENOR TM 60 Preclinical studies 60 dose cohorts 60 clinical trial 60 Phase 2b 60 dosing regimens 60 Homspera 60 methylnaltrexone 60 PROMACTA 60 PXD# 60 Phase III clinical trials 60 Phase 2b clinical 60 oritavancin 60 dose escalation study 60 NGX# 59 tolerability 59 ISIS # 59 Amigal 59 ALTU 59 dose escalation 59 Phase III clinical 59 IDX# 59 LIALDA 59 antiviral activity 59 HGS ETR1 59 safety tolerability pharmacokinetics 59 placebo controlled 59 valopicitabine 59 ProLindac 59 diabetic neuropathic pain 58 PK PD 58 PS# [001] 58 HspE7 58 TRIOLEX 58 orally administered 58 efficacy 58 CoFactor 58 ISENTRESS 58 Mylotarg 58 oral bioavailability 58 calcitonin 58 randomized clinical trials 58 immunogenicity 58 preclinical 58 blinded placebo controlled 58 pivotal Phase III 58 elagolix 58 denufosol 58 DR Cysteamine 58 decitabine 57 Phase III 57 NDA submission 57 genotypic 57 ONGLYZA 57 efficacy endpoints 57 NUVIGIL 57 bifeprunox 57 PEG Interferon lambda 57 sitagliptin 57 MGCD# [001] 57 adalimumab 57 Protectan CBLB# 57 INGN 57 CA4P 57 HuMax CD# 57 vivo efficacy 57 AEZS